Search results
Results From The WOW.Com Content Network
A Q2 update about the progress of a late-stage clinical study provides a nice boost to the clinical-stage biotech stock. Why Inovio Pharmaceuticals, Inc. Stock Is Jumping 12.4% Today Skip to main ...
It traded 0.6% lower in the after-hours at $50.20 per share.See more from Benzinga * Another Chinese Bitcoin Mining Device Maker Files To Go Public In US * Amazon Pilots Online Screening Of New ...
This week, one of the key players in the COVID-19 vaccine race took a leap forward.On Tuesday, Inovio Pharmaceuticals (INO) announced that Thermo Fisher Scientific had signed a letter of intent to ...
Inovio Pharmaceuticals (INO) disappoints with earnings and revenue miss in the second quarter. Shares depreciate in after-hours trading. ... Shares depreciate in after-hours trading. Skip to main ...
In February 2020 after receiving details of the genetic sequence of the coronavirus, Inovio announced that it had produced a preclinical DNA-based vaccine as a potential therapy for COVID-19. [ 7 ] [ 18 ] Inovio is in competition to develop a coronavirus vaccine with numerous other companies, which were conducting preclinical or early-stage ...
For premium support please call: 800-290-4726 more ways to reach us
The more important question is: Why have Inovio's shares fallen for several weeks now?
Investors are not impressed with the biotech's latest plan to raise cash.